Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.32 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.32 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26742877 | 0.86 | MAPT (0.40) | MEN1USP2TNNI3TNNT2TNNC1 | |
| SCHEMBL24752406 | 0.85 | CNR1 (0.37) | MEN1KMT2A | |
| SCHEMBL24495899 | 0.83 | ALDH1A1 (0.34) | — | |
| SCHEMBL24752413 | 0.81 | ALDH1A1 (0.33) | — | |
| SCHEMBL18323681 | 0.79 | KDM4E (0.46) | MEN1KMT2A | |
| SCHEMBL21064229 | 0.78 | KDM4E (0.35) | MEN1TNNI3TNNT2TNNC1KMT2A | |
| SCHEMBL22672123 | 0.78 | MAPT (0.38) | MEN1USP2KMT2A | |
| SCHEMBL25941120 | 0.77 | ALDH1A1 (0.34) | MEN1USP2TNNI3TNNT2TNNC1 | |
| SCHEMBL21871664 | 0.77 | — | — | |
| SCHEMBL18506334 | 0.77 | KDM4E (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814403-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814403-B2 | Organic electroluminescent materials and devices | PDCD1, TEC, PDCD4 | MEN1 495/4885USP2 4833/4885TNNI3 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.